Back to search

Article

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer

2021-11-24

Abstract excerpt

<h4>Background: </h4> Although the Decipher genomic classifier has been validated as a prognostic tool for several prostate cancer endpoints, little is known about its role in assessing risks of biopsy reclassification among patients on active surveillance, a key event that often triggers treatment. <h4>Objective:</h4> To evaluate the association between Decipher genomic classifier and biopsy Gleason upgrade among...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5575a2c0-3128-5ba7-97cc-0a1ea99ee041
DOI
10.1101/2021.11.22.21266727
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate CancerDOI 10.1101/2021.11.22.21266727
Select a neighboring publication to make it the new centre.